Knowledge Transfer Network for Prevention of Mental Diseases and Cancer in the Atlantic Area – PHARMATLANTIC is a project born on necessity to provide involved industries situated in the Atlantic seaboard with research and innovation advances in prevention of mental diseases and cancer already developed by the most specialized centres in this field at EU level.

The problem tackled by the project is the lack of introduction of knowledge from research institutions to SME in the Atlantic Area, furthermore in a field never explored before at EU level which is the use of marine compounds to prevent mental diseases. Other studies and methods have been researched but never before in this way, which is taking into account market needs in terms of knowledge and innovation.

Thus, the main achievements of the project will be the development and introduction of adequate and efficient alternative methods based on antibodies and functional assay. On the other hand, the constitution of Knowledge and Transfer Network PHARMATLANTIC will guarantee the effective and efficient introduction of those methods among pharmacy companies, as well as sustainability of that transference.

For the achievement of these objectives a partnership of 10 EU institutions from Spain, Portugal, France, United Kingdom and Ireland are working where the main research centres, Universities and industries in the field are represented.

The project duration will be 36 months and allocated budget for all the action is 2.152,045.77€.

  • Status
  • Completed
  • Project Launch
  • 01 September 2007
  • Project completed
  • 31 December 2012
pharmaceuticals antibodies knowledge exchange